Cargando…

Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity

Detalles Bibliográficos
Autor principal: Wojta, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328391/
https://www.ncbi.nlm.nih.gov/pubmed/35754015
http://dx.doi.org/10.1111/jth.15728
_version_ 1784757711249866752
author Wojta, Johann
author_facet Wojta, Johann
author_sort Wojta, Johann
collection PubMed
description
format Online
Article
Text
id pubmed-9328391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93283912022-07-30 Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity Wojta, Johann J Thromb Haemost Jth Commentaries John Wiley and Sons Inc. 2022-06-26 2022-07 /pmc/articles/PMC9328391/ /pubmed/35754015 http://dx.doi.org/10.1111/jth.15728 Text en © 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Jth Commentaries
Wojta, Johann
Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title_full Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title_fullStr Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title_full_unstemmed Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title_short Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
title_sort commentary on “elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: a new role for plasminogen activator inhibitor‐1—an inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
topic Jth Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328391/
https://www.ncbi.nlm.nih.gov/pubmed/35754015
http://dx.doi.org/10.1111/jth.15728
work_keys_str_mv AT wojtajohann commentaryonelevatedplasmalevelsofplasminogenactivatorinhibitor1areassociatedwithriskoffutureincidentvenousthromboembolismanewroleforplasminogenactivatorinhibitor1aninhibitoroffibrinolysispredictsfuturevenousthromboemboliceventsandlinksthemtoobesity